As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

Donald Trump’s secretary of state-nominee Marco Rubio said the US should reconsider Chevron Corp.’s sanctions waiver that ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

Read here for more on the potential of RCUS's combination therapies for various cancers, with promising Phase 3 trials and ...